Piper Sandler keeps Axsome Therapeutics price target at $258
Piper Sandler maintained a $258.00 per-share price target for Axsome Therapeutics, per Benzinga (TradingView News).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.